Dr. Gregory Randolph on Pre-Surgical Laryngeal Assessment in Patients With Thyroid Cancer
Randolph says pre-operative loss of voice tracks "robustly" with invasive thyroid cancer, and being aware of this issue before surgery helps surgeons better treat their patients.
Gregory Randolph, MD, FACS, FACE, director, Division of General Otolaryngology, director, Division of Thyroid and Parathyroid Surgery, Massachusetts Eye & Ear Infirm, discusses the new dynamic of voice and laryngeal assessment around surgery for thyroid cancer. Randolph says pre-operative loss of voice tracks "robustly" with invasive thyroid cancer, and being aware of this issue before surgery helps surgeons better treat their patients.
Anticipating Novel Options for the RAI-Refractory DTC Armamentarium
May 15th 2023In season 4, episode 6 of Targeted Talks, Warren Swegal, MD, takes a multidisciplinary look at the RAI-refractory differentiated thyroid cancer treatment landscape, including the research behind 2 promising systemic therapy options.
Listen
